SEC Form 4 · accession 0001078782-16-002279
AXIM BIOTECHNOLOGIES, INC. · AXIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Anastassov
Officer — President · Director · 10% Owner
Period of report
Feb 5, 2016
Accepted (ET)
Feb 5, 2016 · 2:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001514946
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2016 | A | 125,000 | $0.00 | A | 15,365,650 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting Person holds 752,000 shares directly and 14,613,650 shares held by Sanammad Foundation, which Reporting Person is a member